Pentwater Capital Management’s HCA Healthcare HCA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$35.5M Buy
+75,000
New +$37.8M 0.18% 47
2025
Q4
Sell
-253,400
Closed -$108M 94
2025
Q3
$108M Buy
253,400
+93,400
+58% +$36.2M 0.6% 34
2025
Q2
$61.3M Buy
160,000
+67,500
+73% +$24.3M 0.4% 46
2025
Q1
$32M Buy
+92,500
New +$29.8M 0.27% 43
2020
Q4
Sell
-48,700
Closed -$6.07M 248
2020
Q3
$6.07M Sell
48,700
-167,800
-78% -$20.8M 0.08% 79
2020
Q2
$21M Buy
216,500
+74,000
+52% +$7.69M 0.37% 34
2020
Q1
$12.8M Buy
+142,500
New +$18.4M 0.21% 45

Other funds holding HCA

Pentwater Capital Management's HCA Position: Q1 2026 in Review

Pentwater Capital Management opened a new position in HCA Healthcare (HCA) in Q1 2026: 75,000 shares worth $35.5M. The stake represents 0.18% of the portfolio and ranks #47 among its holdings. This is a return to the name: Pentwater Capital Management previously reported a position in HCA as recently as Q3 2025.

Pentwater Capital Management first reported a position in HCA in Q1 2020 and has held it in 7 quarters since. The position peaked at $108M in Q3 2025. 1,414 funds tracked by Wall St. Rank hold HCA as of Q1 2026.

  • Pentwater Capital Management held 75,000 shares of HCA Healthcare worth $35.5M as of Q1 2026.
  • HCA Healthcare was a new Pentwater Capital Management position in Q1 2026.
  • HCA Healthcare made up 0.18% of Pentwater Capital Management's portfolio in Q1 2026, its #47 holding.
  • Pentwater Capital Management first reported a position in HCA Healthcare in Q1 2020 and has held it in 7 quarters since.
  • Pentwater Capital Management's HCA Healthcare position peaked at $108M in Q3 2025.
  • 1,414 funds tracked by Wall St. Rank held HCA Healthcare as of Q1 2026.

Based on Pentwater Capital Management's 13F filing for Q1 2026, filed 15 May 2026.